“Summary
Pacific Edge Limited (PEB) is a medical diagnostics company that discovers and commercializes diagnostic and prognostic technology for the early detection and monitoring of cancer. The company identifies gene and protein signatures for the development of cancer management tools. Its cxbladder is a non-invasive laboratory test for the detection of bladder cancer. PEB is developing prognostic gene signature for patients, who are diagnosed with stage II or stage III colorectal cancer. The company provides diagnostic services through its facilities in New Zealand, Australia, Spain and the US. PEB is headquartered in Dunedin, New Zealand.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
– The report analyzes all pipeline products in development for the company Pacific Edge Limited
– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
– The report provides detailed description of products in development, technical specification and functions
– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
– To formulate effective Research & Development strategies
– Develop market-entry and market expansion strategies
– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio”
“Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Pacific Edge Limited Company Snapshot 6
Pacific Edge Limited Company Overview 6
Key Information 6
Pacific Edge Limited Pipeline Products and Clinical Trials Overview 7
Pacific Edge Limited – Pipeline Analysis Overview 9
Key Facts 9
Pacific Edge Limited – Major Products and Services 10
Pacific Edge Limited Pipeline Products by Development Stage 11
Pacific Edge Limited Pipeline Products Overview 13
Cxbladder 13
Cxbladder Product Overview 13
Cxbladder – Health 14
Cxbladder – Health Product Overview 14
Cxbladder – Prognosis Assay 15
Cxbladder – Prognosis Assay Product Overview 15
Cxbladder Triage 16
Cxbladder Triage Product Overview 16
CxColorectal 17
CxColorectal Product Overview 17
Cxcolorectal – prognosis Gen II 18
Cxcolorectal – prognosis Gen II Product Overview 18
Diagnostic Assay – Gastric Cancer 19
Diagnostic Assay – Gastric Cancer Product Overview 19
Endometrial Cancer Detection Assay 20
Endometrial Cancer Detection Assay Product Overview 20
Gastric Cancer Triage Immunoassay 21
Gastric Cancer Triage Immunoassay Product Overview 21
Prognostic Assay – Melanoma 22
Prognostic Assay – Melanoma Product Overview 22
Pacific Edge Limited – Key Competitors 23
Pacific Edge Limited – Key Employees 24
Pacific Edge Limited – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Pacific Edge Limited, Recent Developments 26
May 25, 2015: Research Shows Pacific Edge’s Cxbladder Detect Outperforms Other Non-Invasive Bladder Cancer Diagnostics 26
May 19, 2015: Pacific Edge’s Cxbladder Triage Accurately Stratifies Patients with Bladder Cancer Symptoms but Low Probability of Bladder Cancer 26
Apr 21, 2015: Pacific Edge seeks additional laboratory accreditation as it pursues international opportunities 27
Mar 18, 2015: Pacific Edge Adds To Its Growing List Of Issued Patents 27
Mar 18, 2015: Cxbladder Triage To Be Showcased In Prestigious Medical Journal 28
Nov 28, 2014: Pacific Edge Reports Commercial Progress and Revenue Growth 29
Nov 26, 2014: Europe Grants Pacific Edge Patent For Colorectal Cancer Prognostic Technology 30
Nov 13, 2014: Pacific Edge announces appointment of Chief Financial Officer 30
Sep 04, 2014: U.S. Grants Pacific Edge Patent for Melanoma Detection 30
Sep 04, 2014: US grants Pacific Edge patent for melanoma detection 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33″
“List of Tables
Pacific Edge Limited, Key Facts 6
Pacific Edge Limited Pipeline Products and Clinical Trials Overview 7
Pacific Edge Limited Pipeline Products by Equipment Type 7
Pacific Edge Limited Pipeline Products by Indication 8
Pacific Edge Limited, Key Facts 9
Pacific Edge Limited, Major Products and Services 10
Pacific Edge Limited Number of Pipeline Products by Development Stage 11
Pacific Edge Limited Pipeline Products Summary by Development Stage 12
Cxbladder – Product Status 13
Cxbladder – Product Description 13
Cxbladder – Health – Product Status 14
Cxbladder – Health – Product Description 14
Cxbladder – Prognosis Assay – Product Status 15
Cxbladder – Prognosis Assay – Product Description 15
Cxbladder Triage – Product Status 16
Cxbladder Triage – Product Description 16
CxColorectal – Product Status 17
CxColorectal – Product Description 17
Cxcolorectal – prognosis Gen II – Product Status 18
Cxcolorectal – prognosis Gen II – Product Description 18
Diagnostic Assay – Gastric Cancer – Product Status 19
Diagnostic Assay – Gastric Cancer – Product Description 19
Endometrial Cancer Detection Assay – Product Status 20
Endometrial Cancer Detection Assay – Product Description 20
Gastric Cancer Triage Immunoassay – Product Status 21
Gastric Cancer Triage Immunoassay – Product Description 21
Prognostic Assay – Melanoma – Product Status 22
Prognostic Assay – Melanoma – Product Description 22
Pacific Edge Limited, Key Employees 24
Pacific Edge Limited, Subsidiaries 25″
“List of Figures
Pacific Edge Limited Pipeline Products by Equipment Type 8
Pacific Edge Limited Pipeline Products by Development Stage 11″
